Article Date

PM Group was delighted to support BioPhorum in co-authoring their latest publication on “Accelerating multi-product biopharmaceutical manufacturing facility project lifecycle through Modular Design”. Our experts worked closely with BioPhorum’s Standard Facility Design Technology Roadmap team

As the biopharma market expands into new modalities, manufacturers need to move faster than ever before to manage multiple, complex product pipelines. To speed up delivery and operation of manufacturing facilities, the industry needs to have greater adoption of both modular design and modular construction. 

In a previous white paper from the same team, the benefits of a modular design approach were outlined using an example of a commercial scale mAbs facility. In this new publication, the approach is applied to a multi-product viral vector facility showing how significant benefits can be gained at each stage of facility design, procurement, construction, qualification and operation.

The paper includes a worked example of a late stage clinical/early commercial viral vector facility.

Download the paper from Biophorum.

Interested in a modular approach to your next project? Get in touch with our experts.

Austin Lock
Austin Lock

Pharmaceutical Sector Technical Director

Austin Lock

Pharmaceutical Sector Technical Director